Important Notice for Zynex, Inc. (ZYXI) Shareholders: Potential Class Action Lawsuit
New York, NY, March 31, 2025 – The Gross Law Firm, a leading national shareholder rights law firm, announces that it has commenced an investigation on behalf of certain shareholders of Zynex, Inc. (NASDAQ: ZYXI) concerning potential securities laws violations. The investigation focuses on whether the Company and its executives violated federal securities laws.
Background
Zynex, Inc. is a medical device and technology company engaged in the manufacture and sale of advanced medical devices, including transcutaneous electrical nerve stimulation (TENS) devices, functional electrical stimulation (FES) systems, and rehabilitation robotics. The Company’s products are used to treat chronic pain, peripheral arterial disease, and other medical conditions.
Class Period and Eligibility
The investigation concerns shares of Zynex, Inc. purchased during the class period, which is typically between the beginning of the public disclosure of the alleged securities laws violations and the filing of a class action lawsuit. Eligible shareholders are encouraged to contact The Gross Law Firm to discuss their legal rights and potential appointment as lead plaintiff in this action.
Details of the Investigation
The Gross Law Firm’s investigation focuses on whether Zynex, Inc. and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose material information to investors. Specifically, the investigation is looking into allegations that the Company may have downplayed or concealed the extent of its business relationship with a particular distributor, which may have resulted in inflated revenue figures and an artificially inflated stock price.
Implications for Individual Shareholders
If it is determined that Zynex, Inc. and its executives have violated securities laws, shareholders who purchased shares during the class period may be able to recover their losses through a class action lawsuit. Shareholders are encouraged to contact The Gross Law Firm to discuss their potential legal rights and options.
Global Impact
The potential impact of this investigation and any resulting class action lawsuit extends beyond individual shareholders. The securities markets rely on accurate and transparent disclosures to function effectively. When companies and executives fail to meet these obligations, investor confidence can be shaken, potentially leading to broader market instability. This is particularly important in the healthcare sector, where accurate and reliable information is critical to ensuring the safety and efficacy of medical treatments and technologies.
Conclusion
The Gross Law Firm’s investigation into potential securities laws violations at Zynex, Inc. is an important step in ensuring that investors are protected and that the securities markets remain fair and transparent. Shareholders who purchased shares during the class period are encouraged to contact the firm to discuss their potential legal rights and options. The potential implications of this investigation extend beyond individual shareholders, underscoring the importance of accurate and transparent disclosures in the healthcare sector and the broader securities markets.
- The Gross Law Firm has commenced an investigation into potential securities laws violations at Zynex, Inc.
- The investigation focuses on whether the Company and its executives downplayed or concealed information regarding a business relationship with a distributor.
- Shareholders who purchased shares during the class period are encouraged to contact the firm to discuss their potential legal rights and options.
- The potential impact of this investigation extends beyond individual shareholders, affecting investor confidence and potentially leading to broader market instability.
